Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 28, 2016; 22(24): 5459-5466
Published online Jun 28, 2016. doi: 10.3748/wjg.v22.i24.5459
Published online Jun 28, 2016. doi: 10.3748/wjg.v22.i24.5459
Natural regression of fibrosis in chronic hepatitis B
Shogo Ohkoshi, Haruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, Department of Internal Medicine, School of Life Dentistry at Niigata, The Nippon Dental University, Niigata 951-8580, Japan
Kenya Kamimura, Masahiko Yano, Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences Niigata University, Niigata 951-8520, Japan
Author contributions: Ohkoshi S wrote the paper; Yano M and Kamimura K collected the data; Hirono H, Watanabe K and Hasegawa K had critical discussions regarding the study and manuscript with Ohkoshi S.
Supported by A Grant-in-Aid for Scientific Research (C) (25461012 to Ohkoshi S) from the Japan Society for the Promotion of Science.
Conflict-of-interest statement: The authors do not have any commercial affiliation or consultancy that could be construed as a conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Shogo Ohkoshi, MD, PhD, Department of Internal Medicine, School of Life Dentistry at Niigata, The Nippon Dental University, 1-8 Hamaura-Cho, Chuo-ku, Niigata 951-8580, Japan. okoshi@ngt.ndu.ac.jp
Telephone: +81-25-2118243 Fax: +81-25-2671582
Received: March 5, 2016
Peer-review started: March 7, 2016
First decision: April 14, 2016
Revised: April 20, 2016
Accepted: May 4, 2016
Article in press: May 4, 2016
Published online: June 28, 2016
Processing time: 108 Days and 1.1 Hours
Peer-review started: March 7, 2016
First decision: April 14, 2016
Revised: April 20, 2016
Accepted: May 4, 2016
Article in press: May 4, 2016
Published online: June 28, 2016
Processing time: 108 Days and 1.1 Hours
Core Tip
Core tip: The fibrosis of liver cirrhosis may be reversible. Regression of fibrosis in hepatitis B virus (HBV) patients with (pre)cirrhosis might be a more common phenomenon than generally considered. This might cause the underestimation of fibrosis levels in chronic hepatitis B, suggesting a difficulty with the surveillance system of HBV-hepatocellular carcinoma (HCC). That is, some HCC patients with non-cirrhotic liver might have been cirrhotic in the past, after which spontaneous regression of fibrosis occurred. Cirrhosis-HCC mechanisms, compared to the direct action of the viral genome, might be more prevalent than generally considered in HBV patients.